Fact CheckerSign in

NCT05497167Completed

Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities

Source: ClinicalTrials.gov · Last updated 31 May 2024

Brief summary (registry, in English)

This study will involve the development, distribution, and evaluation of "period kits" for pre-menarchal adolescents with intellectual and cognitive disabilities (IDD) (e.g., autism spectrum disorder and Down syndrome) in relieving stress and augmenting sense of preparedness regarding imminent pubertal changes.

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
22 Jul 2022
Start date
23 Sept 2022
Primary completion date
29 May 2024
Lead sponsor
Tufts Medical Center
Diseases
Autism
NCT number
NCT05497167

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 23 Sept 2022 to the primary completion date, 29 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Those that do not meet any of the aforementioned criteria
  • Minors who are:
    • married, widowed, divorced; or ii) the parent of a child; or iii) a member of any of the armed forces; or iv) pregnant or believes herself to be pregnant; or v) living separate and apart from his/her parent or legal guardian, and is managing his/her own financial affairs
  • Wards of the state and/or children at risk of becoming wards of the state
  • Non-English speakers

Who the study is looking for

  • Minors from 5 to 17 years of age
  • Those with the capacity to eventually menstruate but who have not yet had a menstrual period
  • Those with an Intellectual and Developmental Disability (IDD), defined here using DSM diagnostic labels: autism spectrum disorder, Global Developmental Delay, Unspecified Neurodevelopmental Disorder (which includes Down Syndrome and fragile-X)

Age in the registry: 5 years to 17 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tufts Medical Center
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.